Skip to main content
ND

NanoGene Diagnostics

NanoGene Diagnostics operates a molecular genetic and anatomical pathology laboratory that provides same-day reporting for kidney diseases, bone marrow disorders, and solid tumor profiling using FDA-approved technologies. Their services enhance diagnostic accuracy and speed, enabling healthcare providers to make timely treatment decisions and improve patient outcomes.

Dubai, United Arab EmiratesFounded 20231200+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Diagnostic delays in kidney diseases, bone marrow disorders, and solid tumor profiling can hinder timely treatment decisions and negatively impact patient outcomes. Traditional pathology services may lack the speed and comprehensive testing menus required for optimal diagnostic accuracy.

Solution

NanoGene Diagnostics is a full-service anatomical pathology and molecular genetics laboratory providing rapid and detailed diagnostic reporting. They offer same-day reporting for kidney diseases, bone marrow disorders, and solid tumor profiling, integrating flow cytometry, cytogenetics, molecular diagnostics, and histopathology into a single report. NanoGene also provides therapeutic apheresis services through partnerships with hospitals, offering procedures such as plasmapheresis, red cell exchange, and photopheresis. Their services aim to equip healthcare providers with the tools needed to optimize patient care through early detection and accurate diagnoses.

Target Audience

The primary target audience includes healthcare providers, hospitals, and medical researchers specializing in oncology, nephrology, and hematology, as well as patients seeking second opinions and advanced diagnostic services.

Features

  • Same-day reporting for key diagnostic areas, including renal pathology, hematopathology, and solid tumor profiling
  • Comprehensive test menu encompassing anatomical pathology and molecular genetic testing
  • Advanced diagnostic technologies, including digital immunofluorescence and high-voltage transmission electron microscopes
  • Integrated reporting system combining flow cytometry, cytogenetics, molecular diagnostics, and histopathology
  • Therapeutic apheresis services, including plasmapheresis, red cell exchange, and photopheresis, performed at affiliated hospitals
  • Mobile apheresis service model, bringing expertise and equipment directly to hospital patient locations
  • NanoLink client portal for secure access to reports and results
This profile is AI-generated and may contain inaccuracies.